Response of porcine hepatocytes in primary culture to plasma from severe viral hepatitis patients

World Journal of Gastroenterology

Volumn 11, Issue 48, 2005, Pages 7585-7590

  Cheng, Yong Bo ^a   Wang, Ying Jie ^a   Zhang, Shi Chang ^a   Liu, Jun ^a   Chen, Zhi ^a   Li, Jia Jia ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bioartificial liver; Cell culture; Plasma toxicity; Porcine hepatocytes

Indexed keywords

AMINOTRANSFERASE; CATALASE; COLLAGENASE; GLUTATHIONE; LACTATE DEHYDROGENASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOARTIFICIAL ORGAN; BLOOD ANALYSIS; CATTLE; CELL DAMAGE; CELL DEATH; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL METABOLISM; CELL STRUCTURE; CELL VACUOLE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; DETOXIFICATION; DISEASE SEVERITY; DNA SYNTHESIS INHIBITION; ENZYME ACTIVITY; FEMALE; GROWTH INHIBITION; HUMAN; LIVER CELL CULTURE; LIVER PERFUSION; MALE; NEWBORN; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; STUDENT T TEST; SWINE; VIRUS HEPATITIS;

EID: 31644442690     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i48.7585     Document Type: Article

References (29)

1. Hui T, Rozga J, Demetriou AA. Bioartificial liver support. J Hepatobiliary Pancreat Surg 2001; 8: 1-15
2. Hughes RD, Cochrane AM, Thomson AD, Murray-Lyon IM, Williams R. The cytotoxicity of plasma from patients with acute hepatic failure to isolated rabbit hepatocytes. Br J Exp Pathol 1976; 57: 348 348-353
3. Gove CD, Hughes RD, Williams R. Rapid inhibition of DNA synthesis in hepatocytes from regenerating rat liver by serum from patients with fulminant hepatic failure. Br J Exp Pathol 1982; 63: 547-553
4. Shi Q Gaylor JD, Cousins R, Plevris J, Hayes PC, Grant MH. The effects of serum from patients with acute liver failure on the growth and metabolism of Hep G2 cells. Artif Organs 1998; 22: 1023-1030
5. McCloskey P, Tootle R, Selden C, Larsen F, Roberts E, Hodgson HJ. Modulation of hepatocyte function in an immortalized human hepatocyte cell line following exposure to liver-failure plasma. Artif Organs 2002; 26: 340-348
6. Pazzi P, Morsiani E, Vilei MT, Granato A, Rozga J, Demetriou AA, Muraca M. Serum bile acids in patients with liver failure supported with a bioartificial liver. Aliment Pharmacol Ther 2002; 16: 1547-1554
7. Rozga J, Williams F, Ro MS, Neuzil DF, Giorgio TD, Backfisch G, Moscioni AD, Hakim R, Demetriou AA. Development of a bioarti.cial liver: properties and function of a hollow module inoculated with livers cells. Hepatology 1993; 17: 258-265
8. Watanabe FD, Mullon CJ, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann Surg 1997; 225: 484-91; discussion 491-494
9. Khalili TM, Navarro A, Ting P, Kamohara Y, Arkadopoulos N, Solomon BA, Demetriou AA, Rozga J. Bioarti.cial liver treatment prolongs survival and lowers incranial pressure in pigs with fulminant hepatic failure. Artif Organs 2001; 25: 566-570
10. Nagaki M, Miki K, Kim YI, Ishiyama H, Hirahara I, Takahashi H, Sugiyama A, Muto Y, Moriwaki H. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix. Dig Dis Sci 2001; 46: 1046-1056
11. Mears DC, Stewart G, Sun J, Woodman K, Bourne R, Wang L, Sheil AG. Experience with a porcine hepatocyte-based bioartificial liver support system. Transplant Proc 2003; 35: 441-442
12. Gu HY, Chen Z, Sa RX, Yuan SS, Chen HY, Ding YT, Yu AM. The immobilization of hepatocytes on 24 nm-sized gold colloid for enhanced hepatocytes proliferation. Biomaterials 2004; 25: 3445-3451
13. Merican I, Guan R, Amarapuka D. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol 2000; 15: 1356-1361
14. Pokorski RJ, Ohlmer U. Long-term morbidity and mortality in Chinese insurance applicants infected with the hepatitis B virus. J Insur Med 2001; 33: 143-164
15. Chen Z, Ding Y, Zhang H. Cryopreservation of suckling pig hepatocytes. Ann Clin Lab Sci 2001; 31: 391-398
16. Wang YJ, Liu HL. Mass isolation and cryopreservation of hepatocytes. In: Wang YJ, eds. Bioartificial Liver. Beijing-China: People's Health Publishing House 2000: 207-2009.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
18. Flendrig LM, la Soe JW, Jorning GG, Steenbeek A, Karlsen OT, Bovee WM, Ladiges NC, te Velde AA, Chamuleau RA. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J Hepatol 1997; 26: 1379-1392
19. Nozato E, Shiraishi M, Nishimaki T. Up-regulation of hepatocyte growth factor caused by an over-expression of transforming growth factor beta, in the rat model of fulminant hepatic failure. J Surg Res 2003; 115: 226-234
20. Hoshino M, Ohiwa T, Hayakawa T, Kamiya Y, Tanaka A, Hirano A, Kumai T, Katagiri K, Miyaji M, Takeuchi T. Effects of dibutyryl cyclic AMP and papaverine on intrahepatocytic bile acid transport. Role of vesicle transport. Scand J Gastroenterol 1993; 28: 833-838
21. Russo P, Taningher M, Pala M, Pisano V, Pedemonte P, De Angeli MT, Carlone S, Santi L, Parodi S. Characterization of the effects induced on DNA in mouse and hamster cells by lithocholic acid. Cancer Res 1987; 47: 2866-2874
22. Kulkarni MS, Cox BA, Yielding KL. Requirements for induction of DNA strand breaks by lithocholic acid. Cancer Res 1982; 42: 2792-2795
23. Drixler TA, Vogten MJ, Ritchie ED. Liver regeneration is an angiogenesis associated phenomenon. Ann Surg 2002; 236: 703-711
24. Albrecht JH, Meyer AH, Hu MY. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration. Hepatology 1997; 25: 557-563
25. Sugiyama A, Nagaki M, Shidoji Y, Moriwaki H, Muto Y. Regulation of cell cycle-related genes in rat hepatocytes by transforming growth factor beta1. Biochem Biophys Res Commun 1997; 238: 539-543
26. Ohiwa T, Katagiri K, Hoshino M, Hayakawa T, Nakai T. Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. Hepatology 1993; 17: 470-476
27. Heuman DM, Pandak WM, Hylemon PB, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991; 14: 920-926
28. Uchino J, Matsue H, Takahashi M, Nakajima Y, Matsushita M, Hamada T, Hashimura E. A hybrid artificial liver system. Function of cultured monolayer pig hepatocytes in plasma from hepatic failure patients. ASAIO Trans 1991; 37: M337-M338
29. Smirthwaite AD, Gaylor JD, Cousins RB, Grant MH. Cytotoxicity of bile in human Hep G2 cells and in primary cultures of rat hepatocytes. Artif Organs 1998; 22: 831-836